Insider · CIK 0001129890
DRISCOLL FREDERICK W
Reports to the SEC for 12 companies · FLORHAM PARK, NJ
Transactions
50
Companies
12
Filings
19
CIK
0001129890
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-07-07 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2025-11-14 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-07-15 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-02-14 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2025-01-02 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2024-06-14 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2024-01-02 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2023-09-29 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-28 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2023-01-03 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2022-07-05 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-24 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2022-03-28 | Renovacor, Inc.OptionA Award | — |
| 2022-01-03 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2021-11-19 | Flexion Therapeutics IncStock option (right to buy)D Disposition to Issuer | — |
| 2021-11-19 | Flexion Therapeutics IncD Disposition to Issuer | −$261K |
| 2021-09-03 | CLRBCellectar Biosciences, Inc.P Purchase | +$20.2K |
| 2021-07-01 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-06-30 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2021-06-01 | Flexion Therapeutics IncA Award | — |
| 2021-06-01 | Flexion Therapeutics IncStock option (right to buy)A Award | — |
| 2021-02-23 | LITSLite Strategy, Inc.S Sale | −$101K |
| 2021-01-04 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2020-08-11 | IBRXImmunityBio, Inc.S Sale | −$511K |
| 2020-08-11 | IBRXImmunityBio, Inc.S Sale | −$99.8K |
| 2020-08-11 | IBRXImmunityBio, Inc.S Sale | −$57.1K |
| 2020-07-02 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-06-24 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2020-06-10 | IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award | — |
| 2020-01-02 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2019-12-19 | LITSLite Strategy, Inc.P Purchase | +$100K |
| 2019-07-01 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-06-13 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2019-06-06 | IBRXImmunityBio, Inc.A Award | — |
| 2019-01-02 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2018-10-12 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2018-07-12 | LITSLite Strategy, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-06-26 | CUECue Biopharma, Inc. · Stock Option (right to buy)A Award | — |
| 2018-06-07 | IBRXImmunityBio, Inc.A Award | — |
| 2018-02-22 | LITSLite Strategy, Inc. · Options to purchase shares of common stockA Award | — |
| 2017-09-18 | IBRXImmunityBio, Inc.A Award | — |
| 2017-05-31 | CLRBCellectar Biosciences, Inc. · Stock option (right to buy)A Award | — |
| 2017-03-23 | Flexion Therapeutics IncStock option (right to buy)M Exercise/Conversion | — |
| 2017-03-23 | Flexion Therapeutics IncM Exercise/Conversion | +$23.7K |
| 2017-03-23 | Flexion Therapeutics IncS Sale | −$69K |
| 2017-02-28 | Flexion Therapeutics IncStock option (right to buy)M Exercise/Conversion | — |
| 2017-02-28 | Flexion Therapeutics IncS Sale | −$12.3K |
| 2017-02-28 | Flexion Therapeutics IncM Exercise/Conversion | +$237K |
| 2017-02-28 | Flexion Therapeutics IncS Sale | −$655K |
| 2016-12-20 | Flexion Therapeutics IncJ Other | +$10.2K |
Recent filings
- 4DRISCOLL FREDERICK W0001104659-26-082016SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001193125-25-286568SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0000929638-25-002634SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001104659-25-014740SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0000950170-25-001106SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001104659-24-072880SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0000950170-24-001829SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0000929638-23-002773SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001104659-23-075938SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001209191-23-001776SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001104659-22-084835SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0000899243-22-025712SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001062993-22-008797SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0000899243-22-001046SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001209191-21-065705SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001104659-21-113416SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001209191-21-045655SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001104659-21-088836SEC(opens sec.gov)
- 4DRISCOLL FREDERICK W0001209191-21-037641SEC(opens sec.gov)
Companies
- Abpro CorpDirector
- Cellectar Biosciences, Inc.DirectorCLRB
- Conformis IncINTERIM CFO & INTERIM TREAS
- Cue Biopharma, Inc.DirectorCUE
- Flexion Therapeutics IncChief Financial Officer
- GENELABS TECHNOLOGIES INC /CACEO/PRESIDENT
- ImmunityBio, Inc.DirectorIBRX
- Invivyd, Inc.Interim CFOIVVD
- Lite Strategy, Inc.DirectorLITS
- NOVAVAX INCVP, CFO & TreasurerNVAX
- Oncotelic Therapeutics, Inc.DirectorOTLC
- Renovacor, Inc.Chief Financial Officer
Address
C/O CELLECTAR BIOSCIENCES, INC. 100 CAMPUS DRIVE
FLORHAM PARK, NJ, 07932